Summary

● From a short-term investment perspective, the company presents a deteriorated fundamental situation

● The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company has attractive valuation levels with a low EV/sales ratio compared with its peers.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the past year, analysts have significantly revised downwards their profit estimates.

● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.